Association between polymorphisms at N-acetyltransferase 1 (NAT1) & risk of oral leukoplakia & cancer

Indian Journal of Medical Research

Volumn 136, Issue 4, 2012, Pages 605-613

  Majumder, Mousumi ^a   Ghosh, Saurabh ^a   Roy, Bidyut ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

Author keywords

Combination of polymorphisms; Leukoplakia; NAT1; NAT2; Oral cancer

Indexed keywords

ACYLTRANSFERASE; CARCINOGEN;

ACETYLATION; ADULT; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENOTYPE; HAPLOTYPE; HUMAN; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRECANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO; WILD TYPE;

ACETYLATION; ARYLAMINE N-ACETYLTRANSFERASE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; ISOENZYMES; LEUKOPLAKIA, ORAL; LINKAGE DISEQUILIBRIUM; MOUTH NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SMOKING;

EID: 84869054601     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-17.
2. World Health Organization. Definition of leukoplakia and related lesions: an aid to studies to precancer. Oral Surg Oral Med Oral Pathol 1978; 46: 517-39.
3. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Comm Dental Oral Epidemiol 1980; 8: 287-33.
4. Sikdar N, Mahmud SA, Paul RR, Roy B. Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 2003; 30: 33-42.
5. Sikdar N, Paul RR, Roy B. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int J cancer 2004; 100: 95-101.
6. Majumder M, Sikdar N, Paul RR, Roy B. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (codon 280). Caner Epidemiol Biomark Prev 2005; 14: 2106-12.
7. Majumder M, Sikdar N, Ghosh S, Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 2007; 120: 2148-56.
8. Anantharaman D, Samnant TA, Sen S, Mahimkar MB. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol 2011; 47: 866-72.
9. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 2007; 28: 1455-62.
10. Nair UJ, Nair J, Mathew B, Bartsch H. Glutathione S-transferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis 1999; 20: 743-8.
11. Ramachandran S, Ramadas K, Hariharan R, Rejnish RK, Pillai MR. Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 2006; 42: 350-62.
12. Agrawal D, Gupta S, Agarwal D, Gupta OP, Agarwal M. Role of GSTM1 and GSTT1 polymorphism: susceptibility to oral submucous fibrosis in the North Indian population. Oncology 2010; 79: 181-6.
13. Butcher NJ, Boukouvala S, Sim E, Minchin RF. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J 2002; 2: 30-42.
14. NAT1 and NAT2 Nomenclature. Available from: http://lousville.edu/medschool/pharmacology/NAT.html.
15. Bell DA, Badawi AF, Lang NP, Ilett KF, Kadlubar FF, Hirvonen A. Polymorphism in N-acetyl transferase 1 (NAT1) polyadenylation signal: association of NAT*10 allele with higher N-acetylation activity in bladder and colon tissue. Cancer Res 1995; 55: 5226-9.
16. Kidd LCR, Vancleave TT, Doll MA, Srivastava DS, Thaker B, Komolafe O, et al. No association between variant N-acetyltransferase genes, cigarette smoking and prostate cancer susceptibility among men of African descent. Biomark Cancer 2011; 3: 1-13.
17. Jourenkova-Mironova N, Wikman H, Bouchardy C, Mitrunen K, Dayer P, Benhamou S, et al. Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers. Pharmacogenetics 1999; 9: 533-7.
18. Katoh T, Keneko S, Boissy R, Watson M, Ikenmura K, Bell DA. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis 1998; 19: 1803-7.
19. Olshan A, Wiessler MC, Watson MA, Bell DA. GSTM1, GST1, GSTP1, CYP1A1 and NAT1 polymorphisms, tobacco use and the risk of head and cancers. Cancer Epidemiol Biomark Prev 2000; 9: 185-91.
20. Hein DW, Doll MA, Fretland AJ, Leff MA, Webb SJ, Xiao GH, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomark Prev 2000; 9: 29-42.
21. Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 2008; 9: 520-31.
22. McKay JD, Hashibe M, Hung RJ, Wakefield J, Gaborieau V, Dabrowska NS, et al. Sequence variants of NAT1 and NAT2 and other xenometabolic genes and risk of lung and aerodigestive tract cancers in central Europe. Cancer Epidemiol Biomark Prev 2008; 17: 141-7.
23. Sharma S, Cao X, Wilkens LR, Yamamoto J, Lum-Jones A, Henderson BE, et al. Well-done meat consumption, NAT1 and NAT2 acetylator genotypes and prostate cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomark Prev 2010; 19: 1866-70.
24. Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adducts formation in the human urinary bladder. Cancer Res 1995; 55: 5230-7.
25. Demokan S, Suoglu Y, Gözeler M, Demir D, Dalay N. N-acetyltransferase 1 and 2 gene sequence variants and risk of head and neck cancer. Mol Biol Rep 2010; 37: 3217-26.
26. Zhao B, Lee EJ, Yeoh PN, Gong NH. Detection of mutations and polymorphisms of N-acetyltransferase 1 gene in Indian, Malay and Chinese populations. Pharmacogenetics 1998; 8: 299-304.
27. Buch SC, Notani PN, Bhisey RA. Polymorphisms at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 2002; 44: 803-7.
28. Lubin JH, Caporaso NE. Cigarette smoking and lung cancer: Modeling total exposure and intensity. Cancer Epidemiol Biomark Prev 2006; 15: 517-23.
29. Doll MA, Hein DW. Rapid genotype method to distinguish frequent and/or functional polymorphisms in human N-acetyltransferase-1. Anal Biochem 2002; 301: 328-32.
30. Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for case-control genetic association analyses. BMC Genet 2008; 9: 36.
31. Crow JF. Eighty years ago: The beginnings of population genetics. Genetics 1988; 119: 473-6.
32. Arslan S, Degerli N, Bardakci F. Distribution of N-acetyltransferase Type 1 (NAT1) genotypes and alleles in a Turkish Population. Genet Mol Biol 2004; 27: 162-4.